Abstract
Among the many models of experimental viral infections, the mouse hepatitis virus (MHV) model offers a number of advantages for investigation of the host-virus relationship:
-
1.
MHV infection is a naturally occurring infection in the mouse (Rowe et al. 1963); Broderson et al. 1976; Ishida et al. 1978) and thus is not an artificial model.
-
2.
In the case of mouse hepatitis virus type 3 (MHV-3), the natural resistance is observed to various degrees according to the mouse strain considered (Virelizier and Allison 1976), with either full susceptibility, full resistance, or semiresistance being present This provides the opportunity to make correlations with parameters of the immune response in a more precise manner than in other models where only two situations (susceptibility and resistance) are observed.
-
3.
The mouse strains showing variable degrees of susceptibility to MHV-3 (namely, A/J, C3H/He, and C57/BL-6) are well-known inbred strains whose biologic parameters have been thoroughly investigated.
-
4.
MHV infections have been among the first models in which the role of macrophages in host defense have been investigated after the pioneering studies of F. Bang and his colleagues (Bang and Warwick 1960; Shif and Bang 1970).
-
5.
MHV-3 induces a very easily recognizable cytopathic effect in mouse macrophage cultures by fusing infected macrophages into multinucleated giant cells (Malucci 1965). The appearance of this cytopathic effect closely parallels the intensity of viral replication and thus provides a useful tool for in vitro studies in macrophages from different strains of mice (Virelizier and Allison 1976).
-
6.
MHV-3 infection is so far the only Coronavirus model in which the protective role of interferon in vivo has been demonstrated (Virelizier and Gresser 1978).
-
7.
Finally, the modification of immune responsiveness during acute or persistent infections has been investigated (Virelizier et al. 1976).
Chapter PDF
References
Allison AC (1965) Genetic factors in resistance against virus infections. Arch Gesamte Virusforsch 17:280–293
Allison AC (1978) Role of macrophages in the immune response. Immunol Rev 40:3
Allison AC, Harington JS, Birbeck M (1966) An examination of the cytotoxic effects of silica on macrophages. J Exp Med 124:141–153
Arnheiter H, Haller O (to be published) Inborn resistance of mice to mouse hepatitis virus type 3 (MHV-3): liver parenchymal cell express phenotype in culture. In: Biochemistry and biology of coronaviruses
Bang FB, Warwick A (1960) Mouse macrophages as host cells for the mouse hepatitis virus and the genetic basis of their susceptibility. Proc Natl Acad Sci USA 46:1065–1075
Baron S (1973) The defensive and biological roles of the interferon system. Front Biol 2:267–280
Boraschi D, Meltzer MS (1979) Defective tumoricidal capacity of macrophages from A/J mice. II: Comparison of the macrophage cytotoxic defect of A/J mice with of lipid A-unresponsive C3H/HeJ mice. J Immunol 122:1592–1597
Broderson JR, Murphy FA, Hierholzer JC (1976) Lethal enteritis in infant mice caused by mouse hepatitis virus. Lab Anim Sci 26:824–827
Cowing C, Pincus SH, Sachs DH, Dickler HB (1978) A subpopulation of adherent accessory cells bearing both I-A and I-E or C subregion antigens is required for antigen specific murine T lymphocyte proliferation. J Immunol 121:1680–1685
De Maeyer E, Jullien P, De Maeyer-Guignard J, Demant P (1975) Effect of mouse genotype on interferon production. II: Distribution of If-1 alleles among inbred strains and transfer of phenotype by grafting bone marrow cells. Immunogenetics 2:151–160
Dick GWA, Niven JSF, Gledhill AW (1956) A virus related to that causing hepatitis in mice. Br J Exp Pathol 37:90–95
Dupuy JM, Levy-Leblond E, Le Prevost C (1975) Immunopathology of mouse hepatitis virus type 3 infection. II. Effect of immunosuppression in resistant mice. J Immunol 114:226–230
Epstein LB, Stevens DA, Merigan TC (1972) Selective increase in lymphocyte interferon response to vaccinia antigen after revaccination. J Clin Invest 50:744–753
Epstein LB, Lee SHS, Epstein CJ (1980) Enhanced sensitivity of trisomy 21 monocytes to the maturation-inhibiting effect of interferon. Cell Immunol 50:191–194
Fauconnier B (1970) Augmentation de la pathogénicité virale par l’emploi de sérum anti-interféron in vivo. CR Acad Sci [D] (Paris) 271:1466–1470
Finter NB (1973) Interferons and inducers in vivo. I. Antiviral effects in experimental animals. Front Biol 2:135–150
Gallily R, Warwick A, Bang FB (1964) Effect of cortisone on genetic resistance to mouse hepatitis virus in vivo and in vitro. Proc Natl Acad Sci USA 51:1158–1164
Gidlund M, Orn A, Wigzell H, Senik A, Gresser I (1978) Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature 273:759–761
Glasgow LA, Habel K (1963) Interferon production by mouse leucocytes in vitro and in vivo. J Exp Med 117:149–155
Gresser I, Tovey MG, Bandu MT, Maury C, Brouty-Boye D (1976a) Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection. J Exp Med 144:1305–1315
Gresser I, Tovey MG, Maury C, Bandu MT (1976b) Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with Herpes simplex, Moloney sarcoma, Vesicular stomatitis, Newcastle disease and influenza viruses. J Exp Med 114:1316–1323
Haller O, Arnheiter H, Gresser I, Lindenmann J (1979) Genetically determined, interferon-dependent resistance to influenza virus in mice. J Exp Med 149:601–612
Hirsch MS, Zisman B, Allison AC (1970) Macrophages and age dependent resistance to herpes simplex virus in mice. J Immunol 104:1160–1165
Ishida T, Taguchi F, Lee Y, Yamada A, Tamura T, Fujiwara K (1978) Isolation of mouse hepatitis virus from infant mice with fatal diarrhea. Lab Anim Sci 28:269–276
Kantoch M, Warwick A, Bang FB (1963) Cellular nature of genetic susceptibility to a virus. J Exp Med 117:781–797
Lampert PW, Sims JK, Kniazeff A J (1973) Mechanism of demyelination in JHM virus encephalomyelitis. Electron microscopic studies. Acta Neuropathol (Berl) 24:76–85
Le Prevost C, Levy-Leblond E, Virelizier JL, Dupuy JM (1975a) Immunopathology of mouse hepatitis virus type 3 infection. I. Role of humoral and cellmediated immunity in resistance mechanisms. J Immunol 114:221–225
Le Prevost C, Virelizier JL, Dupuy JM (1975b) Immunopathology of mouse hepatitis virus type 3 infection. III. Clinical and virologic observation of a persistent viral infection. J Immunol 115: 640–645
Levy-Leblond E, Dupuy JM (1977) Neonatal susceptibility to MHV-3 infection in mice. I. Transfer off resistance. J Immunol 118:1219–1222
Levy-Leblond E, Oth D, Dupuy JM (1979) Genetic study of mouse sensitivity to MHV-3 infection: influence of the H2 complex. J Immunol 122:1359–1362
Lindahl P, Leary P, Gresser I (1972) Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes. Proc Natl Acad Sci USA 69:721–725
Lohmann-Mattes ML, Domizig W, Roder J (1979) Promonocytes have the functional characteristics of natural killer cells. J Immunol 123:1883–1887
McFarland HF, Griffin DE, Johnson RT (1972) Specificity of the inflammatory response in viral encephalitis. I. Adoptive immunization of immunosuppressed mice with Sindbis virus. J Exp Med 136:216–220
McIntosh K (1974) Coronaviruses: a comparative review. Curr Top Microbiol Immunol 63:85–129
Malucci L (1965) Observations on the growth of mouse hepatitis virus (MHV-3) in mouse macrophages. Virology 25:30–37
Mims CA (1964) Aspects of the pathogenesis of virus disease. Bacteriol Rev 28:30–71
Miyai K, Slusser RJ, Ruebner BH (1963) Viral hepatitis in mice: an electron microscopic study. Exp Mol Pathol 2:464–480
Petranyi GG, Kiessling R, Klein G (1975) Genetic control of natural killer lymphocytes in the mouse. Immunogenetics 2:53–61
Piazza M, Pane G, De Ritis F (1977) The fate of MHV-3 after intravenous injection into susceptible mice. Arch Gesamte Virusforsch 22:472–474
Roda SJ, White DO (1976) Cytotoxic macrophages: a rapid nonspecific response to viral infection. J Immunol 117:2067–2072
Rowe WP, Hartley JW, Capps WI (1963) Mouse hepatitis virus infection as a highly contagious, prevalent, enteric infection in mice. Proc Soc Exp Biol Med 112:161–165
Sabin AB (1954) Genetic factors affecting susceptibility and resistance to virus disease of the nervous system. Ass Res New Ment Dis Proc 33:57–65
Schultz RM, Chingos MA (1979) Selective neutralization by anti-interferon globulin of macrophage activation by L-cell interferon, Brucella abortus ether extract, Salmonella typhimurium lipopolysaccharide and polyanions. Cell Immunol 48:52–58
Shif I, Bang FB (1970) In vitro interaction of mouse hepatitis virus and macrophages from genetically resistant mice. I. Adsorption of virus and growth curve. J Exp Med 131:843–850
Stohlman SA, Frelinger JA, Weiner LP (1980) Resistance to fatal central nervous system disease by mouse hepatitis virus, strain JHM. II. Adherent cell-mediated protection. J Immunol 124: 1733–1739
Taguchi F, Hirano N, Kiuchi Y, Fujiwara K (1976) Difference in response to mouse hepatitis virus among susceptible mouse strains. Japan J Microbiol 20:293–302
Tardieu M, Hery C, Dupuy JM (1980) Neonatal susceptibility to MHV-3 infection in mice. II. Role of natural effector marrow cells in transfer of resistance. J Immunol 124:418–423
Valle MJ, Bobrove AM, Strober S, Merigan TC (1975) Immune specific production of interferon by human T cells in combined macrophage-lymphocyte cultures in response to herpes simplex antigen. J Immunol 114:435–441
Virelizier JL (1972) Etude virologique et immunologique d’une virose persistante chez la souris infectée par le virus de l’hépatite murine (MHV-3). MD dissertation, University of Paris-Sud
Virelizier JL (1979a) Pathogenesis of mouse hepatitis virus (MHV-3) infection in various inbred strains of mice. In: Bachmann PA (ed) Mechanisms of viral pathogenesis and virulence. WHO, München, p 251
Virelizier JL (1979b) Effects of immunosuppressive agents on leucocyte interferon production in normal or thymus-deprived mice. Transplantation 27:353–355
Virelizier JL (1980) Immunological aspects of interferon secretion. In: Collier LH, Oxford J (eds) Developments in antiviral chemotherapy. Academic Press, London New York, p 201
Virelizier JL, Allison AC (1976) Correlation of persistent mouse hepatitis (MHV-3) infection with its effect on mouse macrophage cultures. Arch Virol 50:279–285
Virelizier JL, Gresser I (1978) Role of interferon in the pathogenesis of viral diseases of mice as demonstrated by the use of anti-interferon serum. V. Protective role in mouse hepatitis virus type 3 infection of susceptible and resistant strains of mice. J Immunol 120:1616–1619
Virelizier JL, Guy-Grand D (1980) Immune interferon secretion as an expression of immunological memory to transplantation antigens: in vivo generation of long-lived, recirculating memory cells. Eur J Immunol 10:375–379
Virelizier JL, Dayan AD, Allison AC (1975) Neuropathological effects of persistent infection of mice by mouse hepatitis virus. Infect 12:1127–1140
Virelizier JL, Virelizier AM, Allison AC (1976) The role of circulating interferon in the modifications of immune responsiveness by mouse hepatitis virus (MHV-3). J Immunol 117:748–753
Weiner LP (1973) Pathogenesis of demyelination induced by a mouse hepatitis virus (JHM virus). Arch Neurol 28:298–303
Willenborg DO, Shan KV, Bang FB (1973) Effect of cyclophosphamide on the genetic resistance of C3H mice to mouse hepatitis virus. Proc Soc Exp Biol Med 142:762–766
Zisman B, Hirsch MS, Allison AC (1970) Selective effects of anti-macrophage serum, silica and anti-lymphocyte serum on pathogenesis of herpes virus infection of young adult mice. J Immunol 104:1155–1159
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Virelizier, JL. (1981). Role of Macrophages and Interferon in Natural Resistance to Mouse Hepatitis Virus Infection. In: Haller, O. (eds) Natural Resistance to Tumors and Viruses. Current Topics in Microbiology and Immunology, vol 92. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68069-4_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-68069-4_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-68071-7
Online ISBN: 978-3-642-68069-4
eBook Packages: Springer Book Archive